These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
323 related articles for article (PubMed ID: 20424447)
1. Peri-operative pulmonary hypertension in paediatric patients: current strategies in children with congenital heart disease. Gorenflo M; Gu H; Xu Z Cardiology; 2010; 116(1):10-7. PubMed ID: 20424447 [TBL] [Abstract][Full Text] [Related]
2. Management of adult patients with perioperative pulmonary hypertension: technical aspects and therapeutic options. Winterhalter M; Antoniou T; Loukanov T Cardiology; 2010; 116(1):3-9. PubMed ID: 20424446 [TBL] [Abstract][Full Text] [Related]
3. Aerosolized iloprost for pulmonary vasoreactivity testing in children with long-standing pulmonary hypertension related to congenital heart disease. Limsuwan A; Khosithseth A; Wanichkul S; Khowsathit P Catheter Cardiovasc Interv; 2009 Jan; 73(1):98-104. PubMed ID: 19089967 [TBL] [Abstract][Full Text] [Related]
4. Aerosolized iloprost for postoperative pulmonary hypertensive crisis in children with congenital heart disease. Limsuwan A; Wanitkul S; Khosithset A; Attanavanich S; Samankatiwat P Int J Cardiol; 2008 Oct; 129(3):333-8. PubMed ID: 18096256 [TBL] [Abstract][Full Text] [Related]
5. Iloprost for children with pulmonary hypertension after surgery to correct congenital heart disease. Xu Z; Zhu L; Liu X; Gong X; Gattrell W; Liu J Pediatr Pulmonol; 2015 Jun; 50(6):588-95. PubMed ID: 24610631 [TBL] [Abstract][Full Text] [Related]
7. Inhaled iloprost to control residual pulmonary hypertension following pulmonary endarterectomy. Kramm T; Eberle B; Guth S; Mayer E Eur J Cardiothorac Surg; 2005 Dec; 28(6):882-8. PubMed ID: 16242948 [TBL] [Abstract][Full Text] [Related]
8. Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease. Schulze-Neick I; Hartenstein P; Li J; Stiller B; Nagdyman N; Hübler M; Butrous G; Petros A; Lange P; Redington AN Circulation; 2003 Sep; 108 Suppl 1():II167-73. PubMed ID: 12970227 [TBL] [Abstract][Full Text] [Related]
9. Inhaled nitric oxide versus aerosolized iloprost for the treatment of pulmonary hypertension with left heart disease. Yin N; Kaestle S; Yin J; Hentschel T; Pries AR; Kuppe H; Kuebler WM Crit Care Med; 2009 Mar; 37(3):980-6. PubMed ID: 19237907 [TBL] [Abstract][Full Text] [Related]
10. Use of inhaled iloprost for the management of postoperative pulmonary hypertension in congenital heart surgery patients: review of a transition protocol. Vorhies EE; Caruthers RL; Rosenberg H; Yu S; Gajarski RJ Pediatr Cardiol; 2014 Dec; 35(8):1337-43. PubMed ID: 24872141 [TBL] [Abstract][Full Text] [Related]
11. Does inhaled nitric oxide improve survival in operated congenital disease with severe pulmonary hypertension? Sharma R; Raizada N; Choudhary SK; Bhan A; Kumar P; Juneja R; Kothari SS; Saxena A; Venugopal P Indian Heart J; 2001; 53(1):48-55. PubMed ID: 11456141 [TBL] [Abstract][Full Text] [Related]
12. Hemodynamic effects of combination therapy with inhaled nitric oxide and iloprost in patients with pulmonary hypertension and right ventricular dysfunction after high-risk cardiac surgery. Antoniou T; Koletsis EN; Prokakis C; Rellia P; Thanopoulos A; Theodoraki K; Zarkalis D; Sfyrakis P J Cardiothorac Vasc Anesth; 2013 Jun; 27(3):459-66. PubMed ID: 23063102 [TBL] [Abstract][Full Text] [Related]
13. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis]. Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbrück B; Grimminger F; Seeger W Pneumologie; 2000 Mar; 54(3):133-42. PubMed ID: 10783653 [TBL] [Abstract][Full Text] [Related]
14. Hemodynamic effects of inhaled nitric oxide and phosphodiesterase inhibitor (dipyridamole) on secondary pulmonary hypertension following heart valve surgery in adults. Santini F; Casali G; Franchi G; Auriemma S; Lusini M; Barozzi L; Favaro A; Messina A; Mazzucco A Int J Cardiol; 2005 Aug; 103(2):156-63. PubMed ID: 16080974 [TBL] [Abstract][Full Text] [Related]
15. [Immediately effects of inhaled aerosolised iloprost in adult patients with severe pulmonary hypertension secondary to congenital heart diseases]. Zhang CJ; Huang YG; Shen JJ; Huang T; Huang WH; Cui YL; Huang XS Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Jan; 39(1):65-8. PubMed ID: 21418801 [TBL] [Abstract][Full Text] [Related]
19. Comparison of inhaled nitric oxide with aerosolized iloprost for treatment of pulmonary hypertension in children after cardiopulmonary bypass surgery. Loukanov T; Bucsenez D; Springer W; Sebening C; Rauch H; Roesch E; Karck M; Gorenflo M Clin Res Cardiol; 2011 Jul; 100(7):595-602. PubMed ID: 21318559 [TBL] [Abstract][Full Text] [Related]
20. [Effect of nebulised iloprost combined with inhaled nitric oxide and oral sildenafil on lung transplant patients. Therapeutic efficacy in pulmonary hypertension during surgery]. Rabanal Llevot JM; Cimadevilla Calvo B; Cifrian Martinez JM; Ruisanchez Villar C; Mons Lera R Rev Esp Anestesiol Reanim; 2012 Mar; 59(3):142-9. PubMed ID: 22985755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]